Utrecht, the Netherlands – AQTIS Medical™ BV, is proud to announce that the Ellansé™ dermal filler Family has received market approval for Australia. This milestone represents a major step forward in the geographical coverage of the product line, and is expected to have an additional …
Analyst Quote for AQTIS Medical BV
Arjunvasan Ambigapathy, Research Analyst, Frost & Sullivan Frost & Sullivan Technology Innovation Award Conferred on AQTIS Medical BV for its Pioneering Ellansé™. Read the analist quotes from Mr. Arjunvasan Ambigapathy on the Frost & Sullivan website by clicking the image below. You can also read some …
Dermal Filler Innovation of the Year
Utrecht, the Netherlands – AQTIS Medical™ BV, announces that its bioresorbable dermal filler Ellansé™ has been awarded the prestigious Frost & Sullivan award 2011 in the category ‘Dermal Filler Innovation of the Year’. AQTIS Medical™ proudly accepted this prestigious award as recognition of the innovative …
Frost & Sullivan Technology Innovation Award Conferred on AQTIS Medical BV for its Pioneering Ellansé™
The 2011 Frost & Sullivan European Technology Innovation of the Year Award in Dermal Fillers is presented to AQTIS Medical BV in recognition of its pioneering Ellansé™. “This novel range of dermal fillers supports safe and cost-effective treatments in aesthetic medicine and surgery, through immediate …
